PL
ABBV icon

Parkwood LLC’s AbbVie ABBV Stock Holding History

Parkwood LLC’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-2,218
Closed -$215K – 140
2017
Q4 		$215K Buy
+2,218
New +$209K 0.03% 204
2015
Q3 		– Sell
-10,682
Closed -$718K – 490
2015
Q2 		$718K Buy
10,682
+64
+0.6% +$4.18K 0.1% 125
2015
Q1 		$622K Buy
10,618
+78
+0.7% +$4.71K 0.08% 158
2014
Q4 		$690K Sell
10,540
-103,908
-91% -$6.55M 0.09% 98
2014
Q3 		$6.61M Buy
+114,448
New +$6.35M 1.39% 12
2014
Q1 		– Sell
-7,410
Closed -$391K – 166
2013
Q4 		$391K Buy
+7,410
New +$364K 0.1% 84

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Parkwood LLC's ABBV Position: Q1 2018 in Review

Parkwood LLC sold out of AbbVie (ABBV) in Q1 2018, closing a stake of 2,218 shares — an estimated $215K sold.

Parkwood LLC first reported a position in ABBV in Q4 2013 and held it in 6 quarters. The position peaked at $6.61M in Q3 2014. 2,016 funds tracked by Wall St. Rank hold ABBV as of Q1 2018.

  • Parkwood LLC reported no remaining AbbVie position as of Q1 2018 after selling out during the quarter.
  • Parkwood LLC sold 2,218 AbbVie shares in Q1 2018, an estimated $215K.
  • Parkwood LLC first reported a position in AbbVie in Q4 2013 and held it in 6 quarters.
  • Parkwood LLC's AbbVie position peaked at $6.61M in Q3 2014.
  • 2,016 funds tracked by Wall St. Rank held AbbVie as of Q1 2018.

Based on Parkwood LLC's 13F filing for Q1 2018, filed 24 Apr 2018.